This is a pragmatic, randomized, clinical trial addressing patient safety. The proposed trial is a minimal-risk safety trial in which extremely premature infants (less than or equal to 750 birth weight and/or less than 27 weeks gestational age) would be randomized to either a continuous phototherapy regimen or to the 15 min cycled phototherapy regimen.

You may be eligible for this study if you meet the following criteria:

• Conditions: Medical Research
• Age: - 99 Years
• Gender: All